Novel Anti-diabesity Peptide Alkaloids from Allophylus africanus P. Beauv

Current Bioactive Compounds
2023.0

Abstract

Aim The aim of the study was to characterize and investigate the mechanism of action of anti-hyperglycemic and anti-hyperlipidemic constitutents of Allophylus africanus. Background Allophylus africanus P. Beauv is a medicinal plant commonly used in sub-Sahara Africa for the treatment of metabolic disorders and infectious diseases. Objective The objective of the study was to isolate and characterize anti-hyperglycemic and anti-hyperlipidemic chemical constituents from Allophylus africanus, and to investigate the mechanism of their enzymatic inhibitions. Methods The chemical constituents were isolated using various column chromatographic techniques. The anti-hyperlipidemic and anti-hyperglycemic properties of the chemical constituents were investigated by measuring their inhibitory effects on porcine pancreatic lipase and alpha-glucosidase enzymes. Fluorescence quenching constants obtained from Stern-Volmer plots were used to determine the mechanisms of inhibitory action. Results Twelve compounds, of which three were new peptide alkaloids, ethylamino asperphenamate (10), allophylane (11) and allophyline (12), were isolated. The new peptide alkaloids and asperphenamate (9) inhibited porcine pancreatic lipase in a dose-dependent manner with IC50 < 90 mu M. Also, 9, 12, stigmasta-5, 22-dien-3-O-beta-D-glucoside (3) and eudesmenol (5) inhibited alpha-glucosidase enzymes with IC50 < 165 mu M, which was lower than that of standard drug, acarbose (432.16 +/- 6.52 mu M). From the Stern-Volmer plots, 9 and 10 indicated a static quenching, while 11 and 12 suggested the occurrence of both static and dynamic quenching mechanisms on porcine pancreatic lipase. On alpha-glucosidase, only 12 exhibited a concurrent static and dynamic quenching mechanism. Conclusion The anti-diabesity compounds obtained from A. africanus established its potential for the treatment of metabolic disorders. Among the isolated compounds, three have been reported for the first time in nature while others have been reported for the first time in the plant.

Knowledge Graph

Similar Paper

Novel Anti-diabesity Peptide Alkaloids from Allophylus africanus P. Beauv
Current Bioactive Compounds 2023.0
Aporphine alkaloids identified from Xylopia aethiopica and their potential hypoglycemic and hypolipidemic activities
Journal of Functional Foods 2023.0
α-Amylase and α-glucosidase inhibitors from Zanthoxylum chalybeum Engl. root bark
Fitoterapia 2020.0
Antidiabetic potential of phytochemicals isolated from the stem bark of Myristica fatua Houtt. var. magnifica (Bedd.) Sinclair
Bioorganic &amp; Medicinal Chemistry 2018.0
Isolation, Structural Characterization and Antidiabetic Activity of New Diketopiperazine Alkaloids from Mangrove Endophytic Fungus Aspergillus sp. 16-5c
Marine Drugs 2021.0
Synthesis of novel triterpene and N-allylated/N-alkylated niacin hybrids as α-glucosidase inhibitors
European Journal of Medicinal Chemistry 2013.0
Kigelia africana fruit fractions inhibit in vitro alpha-glucosidase activity: a potential natural alpha-glucosidase inhibitor
BMC Complementary Medicine and Therapies 2024.0
Chemodiverse monoterpene indole alkaloids from Kopsia teoi, inhibitory potential against α-amylase, and their molecular docking studies
Fitoterapia 2024.0
Glycogen synthase kinase 3β inhibition and insulin-receptor binding enhancement of compounds isolated from wild leafy vegetable Acalypha alnifolia
Phytomedicine Plus 2022.0
Antidiabetic Activity of an Alkaloid (4a-Methyl-5-(6-Methylhept- 5-En-1-Yl)Octahydro-1H-Cyclopenta[A]Pyridazine) Isolated From Lumnitzera racemosa in Streptozotocin-Induced Diabetic Wistar Rats
International Journal of Pharmaceutical Investigation 2022.0